000 01236 a2200385 4500
005 20250511172525.0
264 0 _c19760315
008 197603s 0 0 eng d
022 _a0301-5149
040 _aNLM
_beng
_cNLM
100 1 _aVyas, G N
245 0 0 _aSpecific immunotherapy proposed for hepatitis B virus infection.
_h[electronic resource]
260 _bDevelopments in biological standardization
_c1975
300 _a350-6 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibody Formation
650 0 4 _aGuinea Pigs
650 0 4 _aHepatitis B
_ximmunology
650 0 4 _aHepatitis B Antibodies
_xadministration & dosage
650 0 4 _aHepatitis B Antigens
650 0 4 _aHumans
650 0 4 _aImmunity, Cellular
650 0 4 _aImmunity, Maternally-Acquired
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aLeukocytes
_ximmunology
650 0 4 _aMice
650 0 4 _aPan troglodytes
_ximmunology
650 0 4 _aRNA
_ximmunology
650 0 4 _aTransfer Factor
700 1 _aSchmid, R
700 1 _aIbrahim, A B
700 1 _aRao, K R
773 0 _tDevelopments in biological standardization
_gvol. 30
_gp. 350-6
999 _c1211621
_d1211621